C45H28Cl3DyN4O9, monoclinic, P21/c (no. 14), a = 13.56(1) Å, b = 19.77(1) Å, c = 15.29(1) Å, β = 102.17(1)°, V = 4006.2 Å3, Z = 4, Rgt(F) = 0.0229, wRref(F2) = 0.0979, T = 296 K
C60H50Co2N9O15, triclinic, P1̅ (no. 2), a = 13.6074(19) Å, b = 13.9185(17) Å, c = 15.837(2) Å, α = 8...
C36H51EuN6O15, triclinic, P (1) over bar (No. 2), a = 11.426(3) Angstrom, b = 13.842(3) Angstrom, c ...
C11H11DyN4O11, monoclinic, P21/c (no. 14), a = 12.073(4) Å, b = 14.704(4) Å, c = 8.763(3) Å, β = 94....
DyC43H67O6N2, triclinic, P1‾$P\overline{1}$ (no. 2), a = 10.384(3) Å, b = 13.502(4) Å, c = 16.972(5)...
C52H32F4N6O14Tb2, triclinic, P1̅ (no. 2), a = 10.745(2) Å, b = 10.993(2) Å, c = 11.141(2) Å, α = ...
C48H58Dy2N4O0, monoclinic, P121/n1 (no. 14), a = 12.6175(7) Å, b = 13.2833(9) Å, c = 15.765(1) Å, β ...
C52H36C14N4O14Pb2·2(H2O), triclinic, P1‾$P‾{1}$ (no. 2), a = 9.1186(4) Å, b = 12.8031(6) Å, c...
C27H54N6O28V10, triclinic, P1‾$P‾{1}$ (no. 2), a = 11.3803(3) Å, b = 14.0832(4) Å, c = 16.235...
International audienceCi(65)H(193)CL(4.36)O(23.64)P(4)U(2), triclinic, P (1) over bar (no. 2), a = 1...
C49H36N4O4Cl2, triclinic, P1‾$P\overline{1}$ (no. 2), a = 6.3858(2) Å, b = 12.6484(4) Å, c = 12.7115...
C54H38Cl6Tb2N10O8, triclinic, P1̄, a = 12.0062(8) Å, b = 12.0072(8) Å, c = 12.2324(8) Å, α = 115.371...
C88H64Cl4N8O12S4Cd2, monoclinic, P21/c (no. 14), a = 13.5247(6) Å, b = 15.3257(7) Å, c = 20.6985(8) ...
C37H29ClO4Sn, monoclinic, P21/c (no. 14), a = 10.4233(3) Å, b = 19.5060(6) Å, c = 14.8084(5) Å, β = ...
C6H25Br3N2O3P2, triclinic, P1̅ (no. 2), a = 10.4183(3) Å, b = 11.5741(3) Å, c = 14.0587(4) Å, α = 87...
C24H17N2O10S2Sm, triclinic, P1̅ (no. 2), a = 10.135(5) Å, b = 10.697(5) Å, c = 11.823(7) Å, ɑ = 94.6...
C60H50Co2N9O15, triclinic, P1̅ (no. 2), a = 13.6074(19) Å, b = 13.9185(17) Å, c = 15.837(2) Å, α = 8...
C36H51EuN6O15, triclinic, P (1) over bar (No. 2), a = 11.426(3) Angstrom, b = 13.842(3) Angstrom, c ...
C11H11DyN4O11, monoclinic, P21/c (no. 14), a = 12.073(4) Å, b = 14.704(4) Å, c = 8.763(3) Å, β = 94....
DyC43H67O6N2, triclinic, P1‾$P\overline{1}$ (no. 2), a = 10.384(3) Å, b = 13.502(4) Å, c = 16.972(5)...
C52H32F4N6O14Tb2, triclinic, P1̅ (no. 2), a = 10.745(2) Å, b = 10.993(2) Å, c = 11.141(2) Å, α = ...
C48H58Dy2N4O0, monoclinic, P121/n1 (no. 14), a = 12.6175(7) Å, b = 13.2833(9) Å, c = 15.765(1) Å, β ...
C52H36C14N4O14Pb2·2(H2O), triclinic, P1‾$P‾{1}$ (no. 2), a = 9.1186(4) Å, b = 12.8031(6) Å, c...
C27H54N6O28V10, triclinic, P1‾$P‾{1}$ (no. 2), a = 11.3803(3) Å, b = 14.0832(4) Å, c = 16.235...
International audienceCi(65)H(193)CL(4.36)O(23.64)P(4)U(2), triclinic, P (1) over bar (no. 2), a = 1...
C49H36N4O4Cl2, triclinic, P1‾$P\overline{1}$ (no. 2), a = 6.3858(2) Å, b = 12.6484(4) Å, c = 12.7115...
C54H38Cl6Tb2N10O8, triclinic, P1̄, a = 12.0062(8) Å, b = 12.0072(8) Å, c = 12.2324(8) Å, α = 115.371...
C88H64Cl4N8O12S4Cd2, monoclinic, P21/c (no. 14), a = 13.5247(6) Å, b = 15.3257(7) Å, c = 20.6985(8) ...
C37H29ClO4Sn, monoclinic, P21/c (no. 14), a = 10.4233(3) Å, b = 19.5060(6) Å, c = 14.8084(5) Å, β = ...
C6H25Br3N2O3P2, triclinic, P1̅ (no. 2), a = 10.4183(3) Å, b = 11.5741(3) Å, c = 14.0587(4) Å, α = 87...
C24H17N2O10S2Sm, triclinic, P1̅ (no. 2), a = 10.135(5) Å, b = 10.697(5) Å, c = 11.823(7) Å, ɑ = 94.6...
C60H50Co2N9O15, triclinic, P1̅ (no. 2), a = 13.6074(19) Å, b = 13.9185(17) Å, c = 15.837(2) Å, α = 8...
C36H51EuN6O15, triclinic, P (1) over bar (No. 2), a = 11.426(3) Angstrom, b = 13.842(3) Angstrom, c ...
C11H11DyN4O11, monoclinic, P21/c (no. 14), a = 12.073(4) Å, b = 14.704(4) Å, c = 8.763(3) Å, β = 94....